Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Lemjabbar-Alaoui H, Hassan OU, Yang Y-W, Buchanan P. Lung cancer: Biology and treatment options. Biochim Biophys Acta. 2015;1856:189–210.

CAS  PubMed  PubMed Central  Google Scholar 

Xiao L, Lan X, Shi X, Zhao K, Wang D, Wang X, et al. Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer. Cell Death Dis. 2017;8:e2803.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJJ, Wu Y-L, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389:299–311.

Article  CAS  PubMed  Google Scholar 

Wang J, Li Z, White J, Zhang L. Lung cancer stem cells and implications for future therapeutics. Cell Biochem Biophys. 2014;69:389–98.

Article  CAS  PubMed  Google Scholar 

Yin H, Deng J. [Advances in lung stem cells and Lung Cancer stem cells]. Zhongguo Fei Ai Za Zhi. 2015;18:633–9.

PubMed  Google Scholar 

Guo W, Qiao T, Li T. The role of stem cells in small-cell lung cancer: evidence from chemoresistance to immunotherapy. Semin Cancer Biol. 2022;87:160–9.

Article  CAS  PubMed  Google Scholar 

Kreso A, Dick JE. Evolution of the cancer stem cell model. Cell Stem Cell. 2014;14:275–91.

Article  CAS  PubMed  Google Scholar 

Ajani JA, Song S, Hochster HS, Steinberg IB. Cancer stem cells: the promise and the potential. Semin Oncol. 2015;42(Suppl 1):S3–17.

Article  CAS  PubMed  Google Scholar 

Hadjimichael C, Chanoumidou K, Papadopoulou N, Arampatzi P, Papamatheakis J, Kretsovali A. Common stemness regulators of embryonic and cancer stem cells. World J Stem Cells. 2015;7:1150–84.

Article  PubMed  PubMed Central  Google Scholar 

Zakaria N, Yusoff NM, Zakaria Z, Lim MN, Baharuddin PJN, Fakiruddin KS, et al. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells. BMC Cancer. 2015;15:84.

Article  PubMed  PubMed Central  Google Scholar 

Xiong D, Ye Y, Fu Y, Wang J, Kuang B, Wang H, et al. Bmi-1 expression modulates non-small cell lung cancer progression. Cancer Biol Ther. 2015;16:756–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng Y, Wang L, Yin L, Yao Z, Tong R, Xue J, et al. Lung Cancer Stem cell markers as therapeutic targets: an update on Signaling pathways and therapies. Front Oncol. 2022;12:873994.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vtorushin SV, Khristenko KY, Zavyalova MV, Perelmuter VM, Litviakov NV, Denisov EV, et al. The phenomenon of multi-drug resistance in the treatment of malignant tumors. Exp Oncol. 2014;36:144–56.

CAS  PubMed  Google Scholar 

Chen Z, Shi T, Zhang L, Zhu P, Deng M, Huang C, et al. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade. Cancer Lett. 2016;370:153–64.

Article  CAS  PubMed  Google Scholar 

MacDonagh L, Gray SG, Breen E, Cuffe S, Finn SP, O’Byrne KJ, et al. Lung cancer stem cells: the root of resistance. Cancer Lett. 2016;372:147–56.

Article  CAS  PubMed  Google Scholar 

Suresh R, Ali S, Ahmad A, Philip PA, Sarkar FH. The role of Cancer Stem cells in recurrent and drug-resistant Lung Cancer. Adv Exp Med Biol. 2016;890:57–74.

Article  PubMed  Google Scholar 

Boldrini L, Gisfredi S, Ursino S, Faviana P, Lucchi M, Melfi F, et al. Expression of endothelin-1 is related to poor prognosis in non-small cell lung carcinoma. Eur J Cancer. 2005;41:2828–35.

Article  CAS  PubMed  Google Scholar 

Rosanò L, Bagnato A. Endothelin therapeutics in cancer: where are we? Am J Physiol Regul Integr Comp Physiol. 2016;310:R469–75.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Z-Y, Chen L-L, Xu W, Sigdel K, Jiang X-T. Effects of silencing endothelin-1 on invasion and vascular formation in lung cancer. Oncol Lett. 2017;13:4390–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tapia JC, Niechi I. Endothelin-converting enzyme-1 in cancer aggressiveness. Cancer Lett. 2019;452:152–7.

Article  CAS  PubMed  Google Scholar 

Niechi I, Silva E, Cabello P, Huerta H, Carrasco V, Villar P, et al. Colon cancer cell invasion is promoted by protein kinase CK2 through increase of endothelin-converting enzyme-1c protein stability. Oncotarget. 2015;6:42749–60.

Article  PubMed  PubMed Central  Google Scholar 

Pérez-Moreno P, Quezada-Meza C, Chavez-Almarza C, Niechi I, Silva-Pavez E, Trigo-Hidalgo C, et al. Phosphorylation of endothelin-converting Enzyme-1c at Serines 18 and 20 by CK2 promotes aggressiveness traits in Colorectal Cancer cells. Front Oncol. 2020;10:1–12.

Article  Google Scholar 

Ruzzene M, Pinna LA. Addiction to protein kinase CK2: a common denominator of diverse cancer cells? Biochim Biophys Acta. 2010;1804:499–504.

Article  CAS  PubMed  Google Scholar 

Borgo C, D’Amore C, Sarno S, Salvi M, Ruzzene M. Protein kinase CK2: a potential therapeutic target for diverse human diseases. Signal Transduct Target Ther. 2021;6:183.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ponce DP, Maturana JL, Cabello P, Yefi R, Niechi I, Silva E, et al. Phosphorylation of AKT/PKB by CK2 is necessary for the AKT-dependent up-regulation of β-catenin transcriptional activity. J Cell Physiol. 2011;226:1953–9.

Article  CAS  PubMed  Google Scholar 

Tapia JC, Torres VA, Rodriguez DA, Leyton L, Quest AFG. Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription. Proc Natl Acad Sci U S A. 2006;103:15079–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yefi R, Ponce DP, Niechi I, Silva E, Cabello P, Rodriguez DA, et al. Protein kinase CK2 promotes cancer cell viability via up-regulation of cyclooxygenase-2 expression and enhanced prostaglandin E2 production. J Cell Biochem. 2011;112:3167–75.

Article  CAS  PubMed  Google Scholar 

Swatek KN, Komander D. Ubiquitin modifications. Cell Res. 2016;26:399–422.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dikic I. Proteasomal and autophagic degradation systems. Annu Rev Biochem. 2017;86:193–224.

Article  CAS  PubMed  Google Scholar 

Mohamed T, Abdul-Hafez A, Uhal BD. Regulation of ACE-2 enzyme by hyperoxia in lung epithelial cells by post-translational modification. J Lung Pulm Respir Res. 2021;8:47–52.

PubMed  PubMed Central  Google Scholar 

Pé